Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04598035 · ClinicalTrials.gov registry record

Epidural Spinal Cord Stimulation for Hypertension in Patients With Neuropathic Pain

A clinical trial of Hypertension and Chronic Pain, sponsored by University of Kansas Medical Center.

Active
Registry status
72
Enrollment target
2
Study locations

NCT04598035: Active study of Hypertension and Chronic Pain, sponsored by University of Kansas Medical Center.

NCT04598035 is a study of Hypertension and Chronic Pain that is active but no longer recruiting, run by University of Kansas Medical Center. The registered enrollment target is 72 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04598035, a study of Hypertension and Chronic Pain, is active but no longer recruiting, sponsored by University of Kansas Medical Center.

ACTIVE NOT RECRUITING
Registry status
72 participants
Enrollment target
2
Study locations

Study Summary

The purpose of the ESCAPE Study is to determine the extent to which epidural spinal cord stimulation (SCS) reduces arterial blood pressure (BP) in patients which chronic low back pain and hypertension. We also aim to determine the extent to which higher baseline BP (i.e., hypertension) predicts reductions in pain following SCS implant. This is an observational study of patients undergoing an implantation of a SCS device.

Primary Outcome

Measurements of blood pressure via arm cuff and finger cuff

Interventions

  • DIAGNOSTIC_TEST Diagnostic Tests

Study Locations (2)

Kansas

  • University of Kansas Clinical and Translational Science Unit (CTSU) - Fairway
  • The Marc A. Asher Comprehensive Spine Center at the Kansas University Medical Center - Kansas City

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2020-11-01
Est. Completion 2025-11-01
University of Kansas Medical Center

408 total trials

What the registry record for NCT04598035 still lists

NCT04598035 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower).

The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Diagnostic Tests is the first listed.

NCT04598035 reports a single indexed study location in Kansas.

Frequently Asked Questions

What is clinical trial NCT04598035 about?

NCT04598035 is a clinical study titled "Epidural Spinal Cord Stimulation for Hypertension in Patients With Neuropathic Pain". The purpose of the ESCAPE Study is to determine the extent to which epidural spinal cord stimulation (SCS) reduces arterial blood pressure (BP) in patients which chronic low back pain and hypertension. We also aim to determine the extent to which higher baseline BP (i.e., hypertension) predicts redu...

What is the current status of trial NCT04598035?

This trial is currently active not recruiting. The enrollment target is 72 participants. The study started on 2020-11-01. Estimated completion is 2025-11-01.

What conditions does trial NCT04598035 study?

This clinical trial studies the following conditions: Hypertension, Chronic Pain, Implanted Stimulation Electrodes.

What interventions are being tested in trial NCT04598035?

The interventions under investigation include: Diagnostic Tests (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04598035?

This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04598035 being conducted?

This trial has 2 study locations across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04598035's enrollment target sits among peer trials

72 330th of 470 higher than 139 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02359253 · 72 participants · NA

    Robot Aided Rehabilitation - Intervention

  • NCT02962661 · 72 participants · Phase 1

    Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

  • NCT03113643 · 72 participants · Phase 1

    SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

  • NCT03187535 · 72 participants · NA

    Effect of TEAS on PONV After Spinal Surgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04598035, the US trial registry maintained by the National Library of Medicine. NCT04598035 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.